Publications found:
466
Sort by:
Psilocybin Market - 2026-2035
US$ 3,400.00
Psilocybin Market reached USD $2.41 Billion in 2025 and is expected to reach USD $6.78 Billion by 2035, growing with a CAGR of 10.90% during the forecast period 2026-2035. The Psilocybin Market emerge...
July 2026
36 pages
Addiction Treatment Market - 2026-2035
US$ 3,400.00
Addiction Treatment Market reached US$ 12.45 Billion in 2025 and is expected to reach US$ 23.9 billion by 2035, growing with a CAGR of 6.70% during the forecast period 2026-2035. The Addiction Treatme...
June 2026
45 pages
Rare Neurological Disease Drugs Market - 2024-2031
US$ 3,400.00
Rare Neurological Disease Drugs Market reached US$ 139.4 billion in 2023 and is expected to reach US$ 269.7 billion by 2031, growing with a CAGR of 8.60% during the forecast period 2026-2031. The Rare...
June 2026
57 pages
Neurotherapeutics Market - 2026-2033
US$ 3,400.00
Neurotherapeutics Market reached US$ 7.64 Billion in 2025 and is expected to reach US$ 11.10Billion by 2033, growing with a CAGR of 4.90% during the forecast period 2026-2033. The Neurotherapeutics Ma...
June 2026
43 pages
Autism Spectrum Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants), By Application (Autistic Disorder, Asperger Syndrome), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Autism Spectrum Disorder Treatment Market The global autism spectrum disorder treatment market size was valued at USD 2.71 billion in 2025 and is projected to grow from USD 2.87 billion in 2026 to USD...
May 2026
150 pages
Neurometabolic Disorders Market - 2026-2033
US$ 3,400.00
Neurometabolic Disorders Marketis is growing with a CAGR of 6.50% during the forecast period 2026-2035. The Neurometabolic Disorders Market emerges as a key focus in DataM Intelligence latest in-depth...
May 2026
50 pages
Ziprasidone Market - 2026-2033
US$ 3,400.00
Ziprasidone Market reached USD 1.26 billion in 2025 and is expected to reach USD 2.28 billion by 2033, growing with a CAGR of 7.20% during the forecast period 2026-2033. The Ziprasidone Market emerges...
May 2026
37 pages
Antipsychotic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Schizophrenia, Bipolar Disorder, Unipolar Disorder, Dementia, Others), By Drug Classification (First Generation (Typical), Second Generation (Atypical)), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Antipsychotic Drugs Market is projected to expand significantly, growing from USD 15.78 Billion in 2025 to USD 26.33 Billion by 2031, at a robust Compound Annual Growth Rate (CAGR) of 8.91%...
May 2026
180 pages
Migraine Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutics {Pain-relieving Medications (Analgesics, Triptans, Ergot Alkaloids, Others), and Preventive Medications (Blood pressure-lowering Medications, Anticonvulsant Drugs, Calcitonin Gene-related Peptide (CGRP) Antagonists, Other Preventative Therapies)}, By Route of Administration (Oral & Nasal v/s Injectables), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Migraine Therapeutics Market is projected to grow from USD 4.31 Billion in 2025 to USD 5.75 Billion by 2031, achieving a CAGR of 4.92%. This market, which involves pharmacological treatment...
May 2026
185 pages
Drug-Resistant Epilepsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Neuromodulation Therapy, Antiseizure Medications, Benzodiazepines, Resective Epilepsy Surgery, Specific Metabolic Treatment, Specific Genetic Treatment, Immunotherapy), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for drug-resistant epilepsy is projected to expand significantly, rising from USD 2.68 billion in 2025 to USD 3.59 billion by 2031, demonstrating a compound annual growth rate (CAGR)...
May 2026
180 pages
Muscle Spasticity Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Baclofen, Botulinum Toxin, Diazepam, Dantrolene Sodium, Others), By Route of Administration (Oral, Intramuscular, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global muscle spasticity market is projected to expand significantly, growing from USD 3.65 billion in 2025 to USD 5.41 billion by 2031, demonstrating a compound annual growth rate of 6.78%. This...
May 2026
192 pages
Neuralgia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Drug-Based, Surgery), By Indication (Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, Trigeminal Neuralgia), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Neuralgia Treatment Market is projected to expand significantly, growing from USD 1.34 billion in 2025 to USD 2.23 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 8.86%. This ma...
May 2026
180 pages
Obsessive-Compulsive Disorder Drugs Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (SSRI (Selective Serotonin Reuptake Inhibitors), TCA (Tricyclic Antidepressant)), By Application (Research Institute, Hospitals & Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Obsessive-Compulsive Disorder Drugs Market is projected to grow from USD 893.14 Million in 2025 to USD 1390.74 Million by 2031, at a 7.66% CAGR. Obsessive-Compulsive Disorder drugs represen...
May 2026
182 pages
Parkinson’s Disease Drugs Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mechanism of Action (Dopamine Agonists, Anticholinergic, MAO-B Inhibitors, Amantadine, Carbidopa-levodopa, COMT Inhibitors, and Other Mechanisms of Action), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Parkinson's Disease Drugs is projected to expand significantly, growing from USD 5.67 Billion in 2025 to USD 8.78 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR)...
May 2026
185 pages
Dementia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indications (Alzheimer's Disease, Lewy Body Dementia, Parkinsons Disease Dementia, Vascular Dementia), By Drug Class (Cholinesterase Inhibitors, Glutamate Inhibitors, MAO Inhibitors), By Region & Competition, 2021-2031F
US$ 4,500.00
The global dementia drugs market is projected to expand significantly, from USD 15.17 billion in 2025 to USD 21.42 billion by 2031, achieving a compound annual growth rate (CAGR) of 5.92%. This market...
May 2026
177 pages
Amyotrophic Lateral Sclerosis (ALS) Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Rilutek (Riluzole), Edaravone (Radicava)), By Treatment Type (Physical Therapy, Speech Therapy, Medication, Respiratory Therapy, Others), By End-Users (Hospitals & Clinics, Research and Academic institutes, others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Amyotrophic Lateral Sclerosis (ALS) Market is projected to expand from USD 787.81 Million in 2025 to USD 1127.05 Million by 2031, reflecting a CAGR of 6.15%. This market encompasses both ph...
May 2026
189 pages
Insomnia Treatment Market - Global Industry Size, Share, Trends, Opportunities and Forecast, Segmented By Type (Acute Insomnia Chronic Insomnia, Onset Insomnia, Maintenance Insomnia, Behavioral Insomnia of Childhood), By Drugs (Eszopiclone, Ramelteon, Zaleplon, Zolpidem, Estazolam, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region & Competition, 2021-2031F
US$ 4,500.00
The global insomnia treatment market is projected to expand significantly, rising from USD 3.82 billion in 2025 to USD 5.32 billion by 2031, demonstrating a compound annual growth rate of 5.68%. This...
May 2026
180 pages
Carbamazepine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Epilepsy, Trigeminal Neuralgia, Bipolar Disorder, Diabetic Neuropathy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global carbamazepine market is projected to expand from USD 1.25 billion in 2025 to USD 1.82 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.46%. Carbamazepine, a widely util...
May 2026
180 pages
Carbidopa Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Idiopathic Parkinson Disease, Postencephalitic Parkinsonism, Symptomatic Parkinsonism, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Carbidopa Market is projected to grow from USD 434.89 Million in 2025 to USD 677.94 Million by 2031, achieving a 7.68% CAGR. Carbidopa, a peripheral decarboxylase inhibitor, is administered...
May 2026
182 pages
Levetiracetam Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Epilepsy, Status Epilepticus, Adjunctive Therapy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global levetiracetam market is projected to expand significantly, rising from USD 1621.11 Million in 2025 to USD 2954.32 Million by 2031, demonstrating a compound annual growth rate of 10.52%. Lev...
May 2026
180 pages
